Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 7:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2449–2472 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Preeclampsia
Interventions: Oxytocin, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 13 Years to 45 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hypertension, Dyslipidemia
Interventions: Amlodipine/Atorvastatin; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 106
States / cities: Birmingham, Alabama • Huntsville, Alabama • Little Rock, Arkansas + 73 more

Conditions: Hypertension
Interventions: Irbesartan, Avapro; Drug
Lead sponsor: Roxane Laboratories; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Hypercholesterolemia, Hypertension
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hypertension, Self-Management, Quality of Life, Compliance, Medication, Compliance, Treatment, Compliance, Patient
Interventions: Not listed
Lead sponsor: Case Western Reserve University; Other
Eligibility: 25 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hypertension, Hypertension (HTN), Blood Pressure, High, Blood Pressure Control
Interventions: Standard medical treatment, Clinical Decision Support Tool; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hypertension
Interventions: Eucommia; Dietary Supplement
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Pulmonary Arterial Hypertension
Interventions: observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi; Drug
Lead sponsor: Actelion; Industry
Eligibility: 18 Years and older
Enrollment: 797 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 75
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 63 more

Conditions: Conditions, Infections, Heart Failure, Renal and Urinary Disorders, Diabetes, Hypertension, Fever, Bronchitis, Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Digital Care Solution as supportive personalized care, Traditional Hospital Level Care; Other
Lead sponsor: OSF Healthcare System; Other
Eligibility: 18 Years and older
Enrollment: 9,654 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Peoria, Illinois

Conditions: Preterm Birth Complication, Preterm Birth, Preterm Birth Recurrence, Preeclampsia, Preeclampsia (PE), Hypertensive Disorders of Pregnancy, Support Program, Stress, Resilience, Psychological, Empowerment, Patient, Emotional Stress, Pregnancy, Pregnancy Complications, Pregnancy Induced Hypertension, Neonates and Preterm Infants, Cervical Insufficiency, Social Determinants of Health (SDOH), Cervical Shortening, Disparities in Pregnancy Complications, Disparities, Prenatal Care, Care Coordination
Interventions: Care coordination, Electronic massage, support gift #1, Support gift #2, Support gift #3, Support gift #4, Additional PTBCARE+ support, Stress reduction toolkit - Visit 1 (V1), PTBCARE+ mobile application (app) and website, Sleep, meditation, and Wellness app, Emergency low blood sugar kit, Low dose aspirin (LDA), Visit #2 Stress Reduction Toolkit; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,228 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Obesity, Morbid, Hypertension, Bariatric Surgery Candidate
Interventions: Antibiotic; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 70 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Preeclampsia
Interventions: Magnesium sulfate 4g loading dose, 1g/hr infusion, Magnesium sulfate 6g loading dose, 2g/hr infusion; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Blood Pressure, Hypertension, Mhealth
Interventions: PACESETTER; Device
Lead sponsor: Northern California Institute of Research and Education; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: San Francisco, California • Charleston, South Carolina • Columbia, South Carolina + 1 more

Conditions: Pulmonary Arterial Hypertension
Interventions: Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 17
States / cities: Phoenix, Arizona • Tucson, Arizona • Sacramento, California + 14 more

Conditions: Cardiovascular Diseases, Hypertension
Interventions: Multicomponent, multi-level intervention targeted at physicians and patients, Usual Care; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: Not listed
Enrollment: 1,039 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension
Interventions: Self-Guided M.A.P. BP Improvement Program, Full Support M.A.P. BP Improvement Program; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,238,835 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 24
States / cities: Crescent City, California • Eureka, California • Los Angeles, California + 15 more

Conditions: Glaucoma, Suspect
Interventions: Pattern Electroretinogram; Diagnostic Test
Lead sponsor: Jorvec Corp.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Preeclampsia
Interventions: Not listed
Lead sponsor: Oklahoma State University Center for Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Chronic Kidney Disease, Hypertension
Interventions: Timing of return of results; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 1,874 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 8
States / cities: Birmingham, Alabama • Gainesville, Florida • Jacksonville, Florida + 3 more

Conditions: Open Angle Glaucoma
Interventions: Simbrinza 0.2%-1% Ophthalmic Suspension, Rocklatan 0.02%-0.005% Ophthalmic Solution, Cosopt PF 2%-0.5% Ophthalmic Solution, Latanoprost 0.005% Ophthalmic Solution; Drug
Lead sponsor: Prairie Eye Center; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Springfield, Illinois

Conditions: Pulmonary Arterial Hypertension
Interventions: ESR-specific PET scan; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 13 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Coronary Artery Disease, Mild Cognitive Impairment, Obesity, Abdominal, Hypertension
Interventions: Metformin, Placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years to 79 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Hypertension
Interventions: Para-aminohippuric Acid, Angiotensin II; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: Technology-enabled Team Care, Enhanced Usual Care; Other
Lead sponsor: East Carolina University; Other
Eligibility: 19 Years and older
Enrollment: 780 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 2
States / cities: Greenville, North Carolina • Wilmington, North Carolina

Search by objective public record fields.

Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High Cholesterol

Self-Management and Resilience Trajectories in African American Adults With Hypertension

Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension

Standardized Eucommia Extract in the Treatment of Hypertension

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program

Analysis of the Virtual Acute Care at Home Experience

Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities

Antibiotics, Gastric Bypass, and the Microbiome

Magnesium Sulfate in Obese Preeclamptics

PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor

Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy

Blood Pressure Control in African Americans

Improving BP Control in Diverse Populations Using BP MAP

CLAD Deconvolved PERG Responses in Glaucoma Patients

A Retrospective Review of the Seasonality of Pre-Eclampsia

Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy

Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost

TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH

Genomic Outcomes of Metformin

Evaluation of Lysine-Specific Demethylase 1

Heart to Heart: BP Control Partners